Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for burn pain control
IRCT201406116186N5Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in burn injury comparing Lidocaine with Placebo (2 arms). Primary endpoint: Burn pain reduction. Started Aug 2014; status: completed.
02
Drugs
lidocaine
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT201406116186N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201406116186N5.